Table 1.
Apoptosis
Cell signaling agent | Organ or action | Reference |
(1) MAP kinases | Human breast cancer cell MCF-11 | 47 |
(2) Fas redistribution in the rafts | Colon cancer cells | 48 |
(3) Ceramide | Breast cancer cells | 49 |
(4) STAT3 and nuclear factor-κB-regulation | Human multiple myceloma cells | 50 |
(5) Protein kinases and p38 kinase | Antitumor activity | 51 |
(6) Src and Stat3 | Breast cancer | 52 |
(7) TRAIL-induced | Mitochondria | 53 |
(8) Phosphorylated Akt and Caspace-9 | MCF7 human breast cancer cells | 54 |
(9) Cdc42 activation of ASK1/JNK | Human leukemia cancer cells | 55 |
(10) Phosphatidylinositol 3′-kinase Akt | Human prostate cancer cells | 56 |
(11) WAF-1/p21-mediated G1 phase | Human epidermoid Carcinoma A431 cells | 57 |
(12) AMPK | Colon cancer cells | 58 |
(13) JNK and c-JUN/AP-1 | Prevented HNE-induced JNK | 59 |
(14) c-Myc | Downregulation in human medulloblastoma | 60 |
(15) ERK | Initiates p53 dependent apoptosis via αVβ3 | 61 |
(16) Caspase-3 | Human breast cancer cell | 62 |
(17) CD95 | Human tumor cells | 63 |
(18) TNBS | Inhibiting Notch pathway | 64 |
(19) p53 and P13K/Akt | Human T-cell acute lymphoblastic leukemia MOLT-4 cells | 65 |